FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stephen Fielding

Research Profile

Chemicals & Drugs

Concepts & Ideas

Physiology

Procedures

Phenomena

Unwanted Pregnancies

Co-author Network

Publications

TOP 3
Emily M Godfrey; Nancy P Chin; Stephen L Fielding; Kevin Fiscella; Ann Dozier
Contraceptive methods and use by women aged 35 and over: A qualitative study of perspectives.
Emily M Godfrey; Anita Anderson; Stephen L Fielding; Leslie Meyn; Mitchell Creinin
Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited.
Justine P Wu; Stephen L Fielding; Kevin Fiscella
The effect of polycarbophil gel (Replens) on bacterial vaginosis: a pilot study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stephen Fielding (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Emily M Godfrey; Nancy P Chin; Stephen L Fielding; Kevin Fiscella; Ann Dozier
Contraceptive methods and use by women aged 35 and over: A qualitative study of perspectives.
BMC women's health 2011;11():5.
2007: Emily M Godfrey; Anita Anderson; Stephen L Fielding; Leslie Meyn; Mitchell Creinin
Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited.
Contraception 2007;75(5):378-82.
2007: Justine P Wu; Stephen L Fielding; Kevin Fiscella
The effect of polycarbophil gel (Replens) on bacterial vaginosis: a pilot study.
European journal of obstetrics, gynecology, and reproductive biology 2007;130(1):132-6.
2005: Tamer Middleton; Eric A Schaff; Stephen L Fielding; Mary Scahill; Caitlin Spencer Shannon; Emily Westheimer; Tracey Wilkinson; Beverly Winikoff
Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
Contraception 2005;72(5):328-32.
2005: Eric A Schaff; Robert DiCenzo; Stephen L Fielding
Comparison of misoprostol plasma concentrations following buccal and sublingual administration.
Contraception 2005;71(1):22-5.
2004: Emily M Godfrey; Jacinda T Mawson; Nancy L Stanwood; Stephen L Fielding; Eric A Schaff
Low-dose mifepristone for contraception: a weekly versus planned postcoital randomized pilot study.
Contraception 2004;70(1):41-6.
2004: Stephen L Fielding; Eric A Schaff
Social context and the experience of a sample of U.S. women taking RU-486 (mifepristone) for early abortion.
Qualitative health research 2004;14(5):612-27.
2002: Eric A Schaff; Stephen L Fielding; Carolyn Westhoff
Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy.
Contraception 2002;66(4):247-50.
2002: Stephen L Fielding; Eric A Schaff; Na-yon Nam
Clinicians' perception of sonogram indication for mifepristone abortion up to 63 days.
Contraception 2002;66(1):27-31.
2002: Shana Katzel; Eric A Schaff; Stephen L Fielding
Randomized trial of a Slip-Coat cannula for early abortion.
Contraception 2002;65(5):369-71.
2002: Stephen L Fielding; Emme Edmunds; Eric A Schaff
Having an abortion using mifepristone and home misoprostol: a qualitative analysis of women's experiences.
Perspectives on sexual and reproductive health 2002;34(1):34-40.
2001: R H Phelps; Eric A Schaff; Stephen L Fielding
Mifepristone abortion in minors.
Contraception 2001;64(6):339-43.
2001: K Walker; Eric A Schaff; Stephen L Fielding; L Fuller
Monitoring serum chorionic gonadotropin levels after mifepristone abortion.
Contraception 2001;64(5):271-3.
2001: Stephen L Fielding; S S Lee; Eric A Schaff
Professional considerations for providing mifepristone-induced abortion.
The Nurse practitioner 2001;26(11):44-54.
2001: Eric A Schaff; Stephen L Fielding; Carolyn Westhoff
Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion.
Contraception 2001;64(2):81-5.
2001: Robert H Allen; Carolyn Westhoff; LJ De Nonno; Stephen L Fielding; Eric A Schaff
Curettage after mifepristone-induced abortion: frequency, timing, and indications.
Obstetrics and gynecology 2001;98(1):101-6.
2001: Eric A Schaff; Stephen L Fielding; Steven H Eisinger; LS Stadalius
Mifepristone and misoprostol for early abortion when no gestational sac is present.
Contraception 2001;63(5):251-4.
2000: LJ De Nonno; Carolyn Westhoff; Stephen L Fielding; Eric A Schaff
Timing of pain and bleeding after mifepristone-induced abortion.
Contraception 2000;62(6):305-9.
2000: Eric A Schaff; Stephen L Fielding; Carolyn Westhoff; C Ellertson; Steven H Eisinger; LS Stadalius; L Fuller
Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.
JAMA : the journal of the American Medical Association 2000;284(15):1948-53.
2000: Eric A Schaff; Stephen L Fielding
A comparison of the Abortion Rights Mobilization and Population Council trials.
Journal of the American Medical Women's Association (1972) 2000;55(3 Suppl):137-40.
2000: Eric A Schaff; Stephen L Fielding; Steven H Eisinger; LS Stadalius; L Fuller
Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.
Contraception 2000;61(1):41-6.